Grace Therapeutics(GRCE)
$1.81-0.04 (-2.43%)
GRCE
Grace Therapeutics earnings date
$1.81
At close:-0.04 (-2.43%)
Want to see GRCE full AI Analyst Report?
Grace Therapeutics (GRCE) Q3 2022 Earnings Report
1,210 Followers
GRCE Q3 2022 EPS Results
- Actual EPS
- -$0.54
- Consensus EPS
- -$0.48
- Beat/Miss
- Missed by -$0.06
- One Year Ago EPS
- -$1.44
GRCE Q3 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 02/14/2022
- Time
- Before Open
- Conference Call
- Monday, February 14, 2022
GRCE Upcoming Earnings
Grace Therapeutics's next earnings date is estimated for February 15, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
GRCE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 15, 2027 | 2027 (Q3) | -0.15- | -0.14 | ― | ― |
| Nov 12, 2026 | 2027 (Q2) | -0.15-0.11 | -0.06 | -83.33% (-0.05) | |
| Aug 13, 2026 | 2027 (Q1) | -0.13-0.91 | -0.21 | -333.33% (-0.70) | |
| Jun 18, 2026 | 2026 (Q4) | -0.23-0.06 | 0.11 | -154.55% (-0.17) | |
| Feb 12, 2026 | 2026 (Q3) | -0.28-0.14 | -0.36 | 61.11% (+0.22) | |
| Nov 13, 2025 | 2026 (Q2) | -0.25-0.06 | -0.3 | 80.00% (+0.24) | |
| Aug 12, 2025 | 2026 (Q1) | -0.22-0.21 | -0.24 | 12.50% (+0.03) | |
| Jun 23, 2025 | 2025 (Q4) | -0.280.11 | -0.17 | 164.71% (+0.28) | |
| Feb 13, 2025 | 2025 (Q3) | -0.34-0.36 | -0.21 | -71.43% (-0.15) | |
| Nov 13, 2024 | 2025 (Q2) | -0.37-0.30 | -0.43 | 30.23% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
